Everolimus for pediatric patients with acute graft-versus-host disease after hematopoietic stem cell transplantation: A pilot study

Acute graft-versus-host disease (aGVHD) is a significant cause of morbidity and mortality after allogeneic hematopoietic stem cell transplantation (HSCT). Due to the poor prognosis for patients not responding to first-line steroids treatment, improvements in aGVHD therapy are needed. Everolimus is a...

Descripción completa

Detalles Bibliográficos
Autores principales: Chao, Yu-Hua, Chang, Yin-Chen, Wu, Han-Ping, Peng, Ching-Tien, Weng, Te-Fu, Wu, Kang-Hsi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2017
Materias:
4800
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5682816/
https://www.ncbi.nlm.nih.gov/pubmed/29095297
http://dx.doi.org/10.1097/MD.0000000000008464

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5682816/
https://www.ncbi.nlm.nih.gov/pubmed/29095297
http://dx.doi.org/10.1097/MD.0000000000008464

Ejemplares similares